Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Amgen

www.amgen.com

One Amgen Center Drive
Thousand Oaks
California
91320-1799
United States

+1 805 447 1000

Activities

Research & Development | Pharmaceutical

Related Companies

  • Icrom SRL
  • Nanoform
  • Starlab
  • PCI Pharma Services
  • Solvias
  • Piramal Pharma Solutions
  • Butterworth Laboratories
  • Hermes Pharma GmbH
  • Ecolab Life Sciences
  • Vectorbuilder Inc
  • Indena
  • Quotient Sciences
  • ProtaGene
  • Actylis – The Partner of Choice

Related Content

Synaffix enters ADCs agreement with Amgen
Synaffix enters ADCs agreement with Amgen
Therapeutic: tezepelumab for asthma
Therapeutic: tezepelumab for asthma
Oxford Nanopore gets cash injection
Oxford Nanopore gets cash injection
GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies
GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap
Amgen and Immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies
Amgen and Immatics enter strategic collaboration to develop novel bispecific cancer immunotherapies
Biocartis and Amgen sign a RAS biomarker testing collaboration in Europe
Biocartis and Amgen sign a RAS biomarker testing collaboration in Europe
Teijin Pharma and Amgen to jointly research and develop new therapy for kidney diseases
Teijin Pharma and Amgen to jointly research and develop new therapy for kidney diseases
A precision medicine approach to developing cancer vaccines
A precision medicine approach to developing cancer vaccines
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Amgen and Daiichi Sankyo to commercialise biosimilars in Japan
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
Hyperparathyroidism - etelcalcetide
Hyperparathyroidism - etelcalcetide
Unilife and Amgen enter US$75m injectable drug delivery systems deal
Unilife and Amgen enter US$75m injectable drug delivery systems deal
Amgen Foundation commits US$4m to bring hands-on biotechnology labs to secondary school students
Amgen Foundation commits US$4m to bring hands-on biotechnology labs to secondary school students
Amgen to buy Dezima Pharma for US$300m in cash
Amgen to buy Dezima Pharma for US$300m in cash
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company